SURVEY REPORT

Lab Leaders are Driving Change with Digital Pathology and AI

The 2025 Laboratory Leadership Report: Insights on Digital Pathology, AI, and Precision Medicine

Precision medicine is no longer a lofty promise — it’s driving more effective therapies and more accurate diagnoses.

A recent survey of 360 lab professionals, conducted by the Dark Intelligence Group on Proscia’s behalf, shows that digital pathology and AI are emerging not only as practical solutions to systemic challenges, they are also key drivers advancing precision medicine. These insights reveal that laboratories aren’t just navigating change — they’re on the brink of advancing a new wave of pathology.

Here’s what we learned:

80% believe precision medicine promises more effective therapies and more accurate diagnoses
59% see digital pathology as critical tools for achieving precision medicine
47% prioritized breadth of functionality when selecting technology solutions

Download the full report for free to see the complete survey results and find out what your peers are thinking.

Concentriq

Concentriq is modern, AI-driven pathology for labs of all sizes

The Concentriq platform spans drug discovery to diagnosis, incorporating best-in-class AI applications, algorithm development tools, and AI-native features to help over 12,000 pathologists and scientists at labs of all sizes realize the promise of precision medicine. Concentriq is trusted by 16 of the top 20 pharmaceutical companies as well as major laboratories who are set to diagnose 32,000 patients per day on the platform this year.

EXPLORE CONCENTRIQ

Ready to transform your lab with AI-driven pathology?

TALK TO US